Development of a screening tool for cardiac involvement in the Sarcoidosis population using cardiac magnetic resonance imaging (MRI)

Not Applicable

Completed

• Conditions: Sarcoidosis; Haematological Disorders; Sarcoidosis, unspecified

• Registration Number: ISRCTN86576368
• Lead Sponsor: Countess of Chester Hospital (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-03-14
• Study Completion: 2015-09-09
• Last Update Posted: 26 October 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

1. Patients with known Sarcoidosis
2. Male and female, aged 18-65 years

Exclusion Criteria

1. Contraindication for cardiac MRI
2. Any other cardiovascular disease (an exercise tolerance test will be done on all participants to assess for ischaemic heart disease)

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Presence of cardiac sarcoid as per cardiac MRI, measured at baseline and 1, 6 and 12 months following baseline investigations

Secondary Outcome Measures

Name	Time	Method
<br> 1. Biomarkers<br> 2. ECG and Echo findings<br><br> Measured at baseline and 1, 6 and 12 months following baseline investigations.<br>